News & Articles

The antibody is being trialed for use in the treatment of B cell Acute Lymphoblastic Leukemia

Horizon's CRISPR-edited knockout cell models to further expand the knowledge available in the Cell Atlas program

On demand webinar looks at nanobodies and the use of high-throughput flow cytometry to increase the throughput of nanobody screening campaigns

Discover the latest technologies and techniques that are revolutionizing immuno-oncology research

Distinguished speaker Dr. Bruce Levine addresses some of the current healthcare challenges that impact the development of new therapies

Adakveo targets key molecule for the prevention of sickle cell pathology

Sartorius Intellicyt addresses challenges such as high cost and purification difficulties and presents possible solutions

Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago

Newly discovered antibodies promise significant improvement over current therapies

The technology allows for the placement of unnatural amino acids into recombinant antibodies at specific sites

Integration of S-LAB with the Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development

Watch this webinar to learn how researchers have implemented accelerated discovery and validation of potent therapeutic mAbs

Watch this webinar to find out how to accelerate your workflow using high-throughput flow cytometry

New collaboration to focus on developing potent Affimer-drug conjugates

MonoRab™; superior antibody generation with a stress-free workflow that ensures delivery of the most clones for application-based testing, 10 different mAb variable chain sequences, and expert level recombinant antibody expression

Ultra-clean deep well and assay microplates to be showcased at the Lab Innovations 2019 exhibition

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

Obtain reproducible assay results by automating key western blotting steps

New HCP detection kits are designed to detect the presence of host cell protein impurities at any phase of your therapeutic development

Watch this on-demand webinar to find out all you need to know about an innovative new method for tackling the first step of mAb purification

AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy.